InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $5.520 -1.83 (-24.90%)+
Announcement
Release
4 May 2026 8:53AM
Price at Release
$7.350
Full Release
download
Summary
Chrysos Corporation Limited has announced a significant milestone in their operations, having processed over one million samples in March 2026, a record for their PhotonAssay™ network, and maintaining this level in April. The company has signed 19 new lease agreements for their PhotonAssay™ technology, expanding their presence in international markets, including partnerships with ALS and Bureau Veritas. Guidance for the fiscal year remains strong, with revenues and EBITDA tracking at the upper end of forecasted ranges. Operational highlights include deployments in Chile and Canada, and plans to accelerate deployments moving into the financial year 2027. The refinancing initiative to reach a total of $200 million is expected to complete by June 30, 2026. Chrysos continues to expand its direct-to-mine solutions, securing additional agreements with Allied Gold for operations in Ethiopia.
Key Points
  • Processed over one million samples in March and April 2026.
  • 19 new PhotonAssay™ lease agreements signed.
  • Expansion into new international regions through partnerships.
  • Revenue and EBITDA on track to meet upper guidance range.
  • Deployments in Chile and Canada completed.
  • Plan to accelerate deployments into FY27.
  • Refinancing to $200 million expected by June 30, 2026.
  • Expansion of direct-to-mine solutions with Allied Gold.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.